Trulieve CEO says medical cannabis reclassification a 'giant step forward for American healthcare'
FBN · Apr 24, 2026 · 4m 34sSign Up Now
Already a subscriber?
Trulieve founder and CEO Kim Rivers discusses the impact of Trump's administration reclassifying state-licensed medical cannabis from Schedule 1 to Schedule 3 on 'Varney & Co.'